Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


22.07.2019

1 Acad Radiol
1 ACS Sens
1 Am J Clin Exp Urol
1 Am J Transl Res
1 Biochem Biophys Res Commun
1 Biomed Res Int
3 BJU Int
1 BMC Cancer
1 BMJ Open
1 Cancer Biomark
1 Cancer Manag Res
1 Cancer Sci
1 Cell Cycle
1 Clin Genitourin Cancer
1 Curr Opin Urol
1 Eur Urol
1 Eur Urol Oncol
1 Exp Ther Med
1 FASEB J
2 Int J Urol
1 J Cancer Res Ther
1 J Cell Physiol
1 Med Sci Monit
2 Medicine (Baltimore)
1 Mol Diagn Ther
1 Sci Rep
1 Technol Cancer Res Treat
1 Trends Cancer
1 Urol Case Rep
1 Urol Oncol
1 Water Res
1 World J Oncol
1 World J Urol
1 Yonago Acta Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acad Radiol

  1. HUISMAN H
    Solid Science of AI Supporting Bladder Cancer CT Reading.
    Acad Radiol. 2019 Jul 17. pii: S1076-6332(19)30320.
    PubMed     Text format    


    ACS Sens

  2. WANG Y, Li Z, Lin Q, Wei Y, et al
    Highly Sensitive Detection of Bladder Cancer-Related miRNA in Urine Using Time-Gated Luminescent Biochip.
    ACS Sens. 2019 Jul 17. doi: 10.1021/acssensors.9b00927.
    PubMed     Text format     Abstract available


    Am J Clin Exp Urol

  3. AMPONSA VO, Shuman L, Ellis J, Wang E, et al
    Carcinogen-induced bladder cancer in the FVB mouse strain is associated with glandular differentiation and increased Cd274/Pdl-1 expression.
    Am J Clin Exp Urol. 2019;7:139-152.
    PubMed     Text format     Abstract available


    Am J Transl Res

  4. ZHANG S, Cao H, Ye L, Wen X, et al
    Cancer-associated methylated lncRNAs in patients with bladder cancer.
    Am J Transl Res. 2019;11:3790-3800.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  5. MONDAL AM, Ma AH, Li G, Krawczyk E, et al
    Fidelity of a PDX-CR model for bladder cancer.
    Biochem Biophys Res Commun. 2019 Jul 11. pii: S0006-291X(19)31325.
    PubMed     Text format     Abstract available


    Biomed Res Int

  6. MAI G, Chen L, Li R, Liu Q, et al
    Common Core Bacterial Biomarkers of Bladder Cancer Based on Multiple Datasets.
    Biomed Res Int. 2019;2019:4824909.
    PubMed     Text format     Abstract available


    BJU Int

  7. RAI BP, Bondad J, Vasdev N, Adshead J, et al
    Robotic versus open radical cystectomy for bladder cancer in adults.
    BJU Int. 2019 Jul 15. doi: 10.1111/bju.14870.
    PubMed     Text format     Abstract available

  8. FILIPPOU P, Smith AB
    A new horizon for bladder preservation in muscle-invasive bladder cancer.
    BJU Int. 2019;124:184-185.
    PubMed     Text format    

  9. MARTINI A, Sfakianos JP, Renstrom-Koskela L, Mortezavi A, et al
    The Natural History of Untreated Muscle Invasive Bladder Cancer.
    BJU Int. 2019 Jul 16. doi: 10.1111/bju.14872.
    PubMed     Text format     Abstract available


    BMC Cancer

  10. ZHANG L, Wu B, Zha Z, Qu W, et al
    Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis.
    BMC Cancer. 2019;19:716.
    PubMed     Text format     Abstract available


    BMJ Open

  11. JAMIL ML, Deebajah M, Sood A, Robinson K, et al
    Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Guerin for patients with high-risk non-muscle invasive bladder cancer.
    BMJ Open. 2019;9:e028287.
    PubMed     Text format     Abstract available


    Cancer Biomark

  12. CHENG Y, Huang C, Mo Y, Wu W, et al
    Long non-coding RNA UCA1 regulates tumor growth by impairing let-7e-dependent HMGA2 repression in bladder cancer.
    Cancer Biomark. 2019 Jul 5. pii: CBM182296. doi: 10.3233/CBM-182296.
    PubMed     Text format     Abstract available


    Cancer Manag Res

  13. LYU L, Xiang W, Zhu JY, Huang T, et al
    Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer.
    Cancer Manag Res. 2019;11:6061-6077.
    PubMed     Text format     Abstract available


    Cancer Sci

  14. QIU S, Deng L, Liao X, Nie L, et al
    Tumor-associated macrophages promote bladder tumor growth through PI3K/AKT signal induced by collagen.
    Cancer Sci. 2019;110:2110-2118.
    PubMed     Text format     Abstract available


    Cell Cycle

  15. BUNCH B, Krishnan N, Greenspan RD, Ramakrishnan S, et al
    TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC).
    Cell Cycle. 2019 Jul 18:1-12. doi: 10.1080/15384101.2019.1638693.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  16. SU S, Gu L, Ma X, Li H, et al
    Comparison of Laparoscopic and Robot-assisted Radical Cystectomy for Bladder Cancer: Perioperative and Oncologic Outcomes.
    Clin Genitourin Cancer. 2019 Jun 19. pii: S1558-7673(18)30605.
    PubMed     Text format     Abstract available


    Curr Opin Urol

  17. SADIGHIAN M, Porten S
    Gender differences in oncologic and functional outcomes in patients with bladder cancer undergoing radical cystectomy with urinary diversion.
    Curr Opin Urol. 2019 Jul 15. doi: 10.1097/MOU.0000000000000660.
    PubMed     Text format     Abstract available


    Eur Urol

  18. PEDERZOLI F, Bandini M, Briganti A, Plimack ER, et al
    Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect.
    Eur Urol. 2019 Jul 11. pii: S0302-2838(19)30522.
    PubMed     Text format     Abstract available


    Eur Urol Oncol

  19. DUDDERIDGE T, Stockley J, Nabi G, Mom J, et al
    A Novel, non-invasive Test Enabling Bladder Cancer Detection in Urine Sediment of Patients Presenting with Haematuria-A Prospective Multicentre Performance Evaluation of ADXBLADDER.
    Eur Urol Oncol. 2019 Jul 12. pii: S2588-9311(19)30081.
    PubMed     Text format     Abstract available


    Exp Ther Med

  20. XIE X, Lin J, Zhong Y, Fu M, et al
    FGFR(3S249C) mutation promotes chemoresistance by activating Akt signaling in bladder cancer cells.
    Exp Ther Med. 2019;18:1226-1234.
    PubMed     Text format     Abstract available


    FASEB J

  21. ZHANG YP, Liu KL, Wang YX, Yang Z, et al
    Down-regulated RBM5 inhibits bladder cancer cell apoptosis by initiating an miR-432-5p/beta-catenin feedback loop.
    FASEB J. 2019 Jul 18:fj201900537R. doi: 10.1096/fj.201900537.
    PubMed     Text format     Abstract available


    Int J Urol

  22. OSAWA T, Wei JT, Abe T, Kako Y, et al
    Development of the Japanese version of the health-related quality of life questionnaire for bladder cancer patients using the Bladder Cancer Index: A pilot study.
    Int J Urol. 2019 Jul 16. doi: 10.1111/iju.14073.
    PubMed     Text format    

  23. KOBAYASHI T
    Editorial Comment from Dr Kobayashi to Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induc
    Int J Urol. 2019 Jul 21. doi: 10.1111/iju.14075.
    PubMed     Text format    


    J Cancer Res Ther

  24. HU SW, Wu CC, Chen KC, Ho CH, et al
    Modified U-Shaped ileal neobladder designed for facilitating neobladder-urethral anastomosis in extracorporeal reconstruction after robotic-assisted radical cystectomy.
    J Cancer Res Ther. 2019;15.
    PubMed     Text format     Abstract available


    J Cell Physiol

  25. JIANG D, Zhang Y, Yang L, Lu W, et al
    Long noncoding RNA HCG22 suppresses proliferation and metastasis of bladder cancer cells by regulation of PTBP1.
    J Cell Physiol. 2019 Jul 15. doi: 10.1002/jcp.29090.
    PubMed     Text format     Abstract available


    Med Sci Monit

  26. WU D, Lin J, Zhu Y, Zhang H, et al
    Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and Overall Survival in Patients with Bladder Cancer.
    Med Sci Monit. 2019;25:5289-5298.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  27. LU M, Chen S, Zhou Q, Wang L, et al
    Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1): A study based on 477 patients.
    Medicine (Baltimore). 2019;98:e16426.
    PubMed     Text format     Abstract available

  28. YANG F, Zhou Q, Meng L, Xing N, et al
    IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype.
    Medicine (Baltimore). 2019;98:e16009.
    PubMed     Text format     Abstract available


    Mol Diagn Ther

  29. LI Q, Wang H, Peng H, Huang Q, et al
    MicroRNAs: Key Players in Bladder Cancer.
    Mol Diagn Ther. 2019 Jul 19. pii: 10.1007/s40291-019-00410.
    PubMed     Text format     Abstract available


    Sci Rep

  30. DUENAS M, Perez-Figueroa A, Oliveira C, Suarez-Cabrera C, et al
    Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status.
    Sci Rep. 2019;9:10362.
    PubMed     Text format     Abstract available


    Technol Cancer Res Treat

  31. HU X, Feng H, Huang H, Gu W, et al
    Downregulated Long Noncoding RNA PART1 Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer.
    Technol Cancer Res Treat. 2019;18:1533033819846638.
    PubMed     Text format     Abstract available


    Trends Cancer

  32. GHANDOUR R, Singla N, Lotan Y
    Treatment Options and Outcomes in Nonmetastatic Muscle Invasive Bladder Cancer.
    Trends Cancer. 2019;5:426-439.
    PubMed     Text format     Abstract available


    Urol Case Rep

  33. TSUCHIYAMA K, Ito H, Seki M, Inai K, et al
    Advanced bladder cancer with malignant psoas syndrome: A case report with a focus on physical findings and complications.
    Urol Case Rep. 2019;26:100958.
    PubMed     Text format     Abstract available


    Urol Oncol

  34. HENSLEY PJ, Kyprianou N, Purdom MS, He D, et al
    Predictive value of phenotypic signatures of bladder cancer response to cisplatin-based neoadjuvant chemotherapy.
    Urol Oncol. 2019 Jul 17. pii: S1078-1439(19)30249.
    PubMed     Text format     Abstract available


    Water Res

  35. DIANA M, Felipe-Sotelo M, Bond T
    Disinfection byproducts potentially responsible for the association between chlorinated drinking water and bladder cancer: A review.
    Water Res. 2019;162:492-504.
    PubMed     Text format     Abstract available


    World J Oncol

  36. CASSELL A, Yunusa B, Jalloh M, Mbodji MM, et al
    Non-Muscle Invasive Bladder Cancer: A Review of the Current Trend in Africa.
    World J Oncol. 2019;10:123-131.
    PubMed     Text format     Abstract available


    World J Urol

  37. LLORENTE C, Guijarro A, Hernandez V, Fernandez-Conejo G, et al
    Effect of hospital volume on 90-day mortality after radical cystectomy for bladder cancer in Spain.
    World J Urol. 2019 Jul 13. pii: 10.1007/s00345-019-02874.
    PubMed     Text format     Abstract available


    Yonago Acta Med

  38. KIMURA Y, Honda M, Morizane S, Hikita K, et al
    Effect of Intravesical Bacilli Calmette-Guerin Therapy After Second Transurethral Resection in Stage Ta T1 High-Grade Bladder Cancer.
    Yonago Acta Med. 2019;62:191-197.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: